Description:
Resiquimod is an imidazoquinolinamine and TLR7 agonist with antitumor and antiviral activity.
- Molecular Weight:314.38
- Boiling Point:553.6±50.0°C at 760 mmHg
- Melting Point:193-195°C
- Purity:≥95%
Molecular Formula:
C17H22N4O2
Canonical SMILES:
CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
InChI:
InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)
InChIKey:
BXNMTOQRYBFHNZ-UHFFFAOYSA-N
Solubility:
Soluble in DMSO
Appearance:
White to Pale Yellow Solid
Application:
Resiquimod may be used in immunological and cancer-related cell signaling studies.
Storage: Store at -20°C
Synonyms:
R-848; R 848; R848; S 28463; S-28463; S28463; 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-α,α-dimethyl-; 4-Amino-2-(ethoxymethyl)-α,α-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol; 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol; 4-Amino-2-(ethoxymethyl)-1-(2-hydroxyisobutyl)imidazo[4,5-c]quinoline; Resimiquimod Weitere Informationen finden Sie
hier